Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI

BACKGROUND: There is a paucity of real-world data regarding the clinical impact of dual antiplatelet therapy (DAPT) interruption (temporary or permanent) among patients at high ischemic risk. The aim of this study was to assess the risk of cardiovascular events after interruption of DAPT in high-ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao-Yu, Xu, Bo, Song, Chen-Xi, Guan, Chang-Dong, Xie, Li-Hua, Zhao, Yan-Yan, Cai, Zhong-Xing, Yuan, Sheng, Dou, Ke-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776446/
https://www.ncbi.nlm.nih.gov/pubmed/35095347
http://dx.doi.org/10.1155/2022/3895205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776446/
https://www.ncbi.nlm.nih.gov/pubmed/35095347
http://dx.doi.org/10.1155/2022/3895205

Ejemplares similares